<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="23" left="55" width="517" height="33" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="77" left="138" width="53" height="12" font="1">Sep 12, 2011</text>
<text top="359" left="94" width="337" height="12" font="1">Goat polyclonal IgG, epitope mapping at the C-terminus of IRF-4 of mouse origin.</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="53" height="12" font="2">Western Blot</text>
<text top="134" left="326" width="102" height="12" font="1">fpauli@hudsonalpha.org</text>
<text top="134" left="83" width="61" height="12" font="1">Florencia Pauli</text>
<text top="215" left="121" width="63" height="12" font="1">IRF4_(SC-6059)</text>
<text top="215" left="339" width="18" height="12" font="1">IRF4</text>
<text top="170" left="230" width="25" height="12" font="1">Myers</text>
<text top="255" left="239" width="107" height="12" font="1">Santa Cruz Biotechnology</text>
<text top="485" left="361" width="22" height="12" font="1">Goat </text>
<text top="300" left="395" width="23" height="12" font="1">I0106</text>
<text top="300" left="215" width="32" height="12" font="1">sc-6059</text>
<text top="521" left="395" width="54" height="12" font="2">IP-Mass Spec</text>
<text top="561" left="356" width="43" height="12" font="2">Polyclonal</text>
<text top="419" left="94" width="393" height="12" font="1">Transcription regulatory factor that mediates signaling by type I IFNs (IFN-alpha and IFN-beta). </text>
<text top="431" left="94" width="2" height="12" font="1"> </text>
<text top="443" left="94" width="119" height="12" font="1">Gene Entrez ID 3662.  52 kDa</text>
<text top="599" left="238" width="180" height="12" font="1">http://www.scbt.com/datasheet-6059-irf-4-</text>
<text top="611" left="238" width="84" height="12" font="1">m-17-antibody.html</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="74" left="125" width="95" height="12" font="1">Western blot protocol: </text>
<text top="86" left="125" width="428" height="12" font="1">Whole cell lysate was immunoprecipitated using primary antibody, and the IP fraction was loaded on a </text>
<text top="98" left="125" width="422" height="12" font="1">12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. After separation, the samples </text>
<text top="110" left="125" width="422" height="12" font="1">were transferred to a nitrocellulose membrane with an Invitrogen iBlot system.  Blotting with primary </text>
<text top="122" left="125" width="422" height="12" font="1">(same as that used for IP) and secondary HRP-conjugated antibodies was performed on an Invitrogen </text>
<text top="134" left="125" width="414" height="12" font="1">BenchPro 4100 system. Visualization was achieved using SuperSignal West Femto solution (Thermo </text>
<text top="146" left="125" width="47" height="12" font="1">Scientific).  </text>
<text top="158" left="125" width="2" height="12" font="1"> </text>
<text top="170" left="125" width="429" height="12" font="1">Results: Band of expected size (52 kDa) visualized, representing strongest signal in the lane.   IRF4 is not </text>
<text top="182" left="125" width="255" height="12" font="1">expressed in K562 and therefore serves as a negative control. </text>
<text top="194" left="125" width="2" height="12" font="1"> </text>
<text top="206" left="125" width="419" height="12" font="1">Figure legend: IP-western with sc-6059 in whole cell lysate (WCL) of GM12878 and K562; PM=protein </text>
<text top="218" left="125" width="431" height="12" font="1">marker. IRF4 band is indicated.  IRF4 is not expressed in K562 and therefore serves as a negative control. </text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="99" left="130" width="144" height="12" font="1">IP followed by mass spectrometry: </text>
<text top="111" left="130" width="404" height="12" font="1">Briefly, GM12878 whole cell lysates were immunoprecipitated using primary antibody, and the IP </text>
<text top="123" left="130" width="418" height="12" font="1">fraction was loaded on a 12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. Gel </text>
<text top="135" left="130" width="419" height="12" font="1">was stained with Coomassie Blue in order to visualize marker bands. Gel fragments corresponding to </text>
<text top="147" left="130" width="397" height="12" font="1">the bands indicated above in the western blot image were excised and sent to the University of </text>
<text top="159" left="130" width="403" height="12" font="1">Alabama at Birmingham Cancer Center Mass Spectrometry/Proteomics Shared Facility. There the </text>
<text top="171" left="130" width="415" height="12" font="1">samples were run on an LTQ XL Linear Ion Trap Mass Spectrometer by LC-ESI-MS/MS. Peptides were </text>
<text top="183" left="130" width="423" height="12" font="1">identified using SEQUEST tandem mass spectra analysis, with probability based matching at p &lt; 0.05.  </text>
<text top="195" left="130" width="2" height="12" font="1"> </text>
<text top="207" left="130" width="268" height="12" font="1">As per ENCODE data standards, all SEQUEST results are attached </text>
<text top="219" left="130" width="408" height="12" font="1">(ENCODE_HAIB_IRF4_sc6059_09122011_MassSpec.pdf), including common contaminants. Target </text>
<text top="231" left="130" width="168" height="12" font="1">protein is listed as hit 6 in ~50 kDa band.</text>
<text top="695" left="268" width="68" height="12" font="1">Submit by Email</text>
</page>
<page number="4" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="3" size="11" family="Times" color="#000000"/>
	<fontspec id="4" size="10" family="Times" color="#000000"/>
	<fontspec id="5" size="7" family="Times" color="#000000"/>
<text top="72" left="77" width="282" height="16" font="3"><b>Validation 2: Mass Spectrometry Analysis </b></text>
<text top="98" left="77" width="467" height="13" font="4">ENCODE data standards recognizes various methodologies for secondary validation of </text>
<text top="112" left="77" width="467" height="13" font="4">antibodies.  Among  these  methodologies  is  immunoprecipitation  followed  by  mass </text>
<text top="126" left="77" width="467" height="13" font="4">spectrometry  analysis.  Briefly,  GM12878  whole  cell  lysates  were  immunoprecipitated </text>
<text top="140" left="77" width="467" height="13" font="4">using primary antibody, and the IP fraction was loaded on a 12% acrylamide gel and </text>
<text top="154" left="77" width="467" height="13" font="4">separated with a Bio-Rad PROTEAN II xi system. Gel was stained with Coomasie Blue </text>
<text top="167" left="77" width="467" height="13" font="4">in order to visualize marker bands. A gel fragment corresponding to the band indicated </text>
<text top="181" left="77" width="467" height="13" font="4">above in the western blot image was excised and sent to the University of Alabama at </text>
<text top="195" left="77" width="467" height="13" font="4">Birmingham Cancer Center Mass Spectrometry/Proteomics Shared Facility. There the </text>
<text top="209" left="77" width="467" height="13" font="4">sample  was  run  on  an  LTQ  XL  Linear  Ion  Trap  Mass  Spectrometer  with  alternating </text>
<text top="223" left="77" width="467" height="13" font="4">collision-induced  dissociation  and  electron-transfer  dissociation.  Peptides  were </text>
<text top="236" left="77" width="467" height="13" font="4">identified using MASCOT (Matrix Science), with probability based matching at p &lt; 0.05. </text>
<text top="250" left="77" width="467" height="13" font="4">Subsequent  analysis  was  performed  in  Scaffold  (Proteome  Software,  Inc.)  at  0.0% </text>
<text top="264" left="77" width="467" height="13" font="4">protein  FDR  and  1.8%  peptide  FDR.  As  per  ENCODE  data  standards,  all  Scaffold </text>
<text top="278" left="77" width="467" height="13" font="4">results are listed below, including common contaminants. Target protein is highlighted </text>
<text top="292" left="77" width="65" height="13" font="4">in bold font. </text>
<text top="315" left="77" width="3" height="13" font="4"> </text>
<text top="339" left="90" width="450" height="11" font="2">1.  ATP  synthase  subunit  beta,  mitochondrial  n=1  Tax=Homo  sapiens  RepID=ATPB_HUMAN</text>
<text top="356" left="108" width="3" height="11" font="2"> </text>
<text top="356" left="126" width="58" height="11" font="2">P06576 (+1) </text>
<text top="374" left="90" width="453" height="11" font="2">2.  cDNA  FLJ52842,  highly  similar  to  Actin,  cytoplasmic  1  n=1  Tax=Homo  sapiens </text>
<text top="391" left="108" width="115" height="11" font="2">RepID=B4E335_HUMAN </text>
<text top="391" left="234" width="59" height="11" font="2">B4E335 (+7) </text>
<text top="408" left="90" width="301" height="11" font="2">3.  Alpha-enolase n=1 Tax=Homo sapiens RepID=ENOA_HUMAN </text>
<text top="408" left="414" width="37" height="11" font="2">P06733 </text>
<text top="425" left="90" width="312" height="11" font="2">4.  Tubulin beta-2C chain n=3 Tax=Eutheria RepID=TBB2C_HUMAN </text>
<text top="425" left="414" width="58" height="11" font="2">P68371 (+1) </text>
<text top="443" left="90" width="370" height="11" font="2">5.  Pyruvate kinase isozymes M1/M2 n=2 Tax=Homininae RepID=KPYM_HUMAN </text>
<text top="443" left="486" width="37" height="11" font="2">P14618 </text>
<text top="460" left="90" width="374" height="11" font="5"><b>6.  Interferon regulatory factor 4 n=1 Tax=Homo sapiens RepID=IRF4_HUMAN </b></text>
<text top="460" left="486" width="38" height="11" font="5"><b>Q15306 </b></text>
<text top="477" left="108" width="21" height="11" font="5"><b>(+1) </b></text>
<text top="494" left="90" width="453" height="11" font="2">7.  cDNA  FLJ78244,  highly  similar  to  Homo  sapiens  eukaryotic  translation  initiation  factor  4A, </text>
<text top="512" left="108" width="346" height="11" font="2">isoform 1 (EIF4A1), mRNA n=1 Tax=Homo sapiens RepID=A8K7F6_HUMAN </text>
<text top="512" left="486" width="39" height="11" font="2">A8K7F6 </text>
<text top="529" left="108" width="21" height="11" font="2">(+1) </text>
<text top="546" left="90" width="450" height="11" font="2">8.  ATP  synthase  subunit  alpha,  mitochondrial  n=3  Tax=Homininae  RepID=ATPA_HUMAN</text>
<text top="563" left="108" width="3" height="11" font="2"> </text>
<text top="563" left="126" width="37" height="11" font="2">P25705 </text>
<text top="581" left="90" width="111" height="11" font="2">9.  6-phosphogluconate </text>
<text top="581" left="218" width="74" height="11" font="2">dehydrogenase, </text>
<text top="581" left="310" width="73" height="11" font="2">decarboxylating </text>
<text top="581" left="400" width="20" height="11" font="2">n=3 </text>
<text top="581" left="437" width="52" height="11" font="2">Tax=Homo </text>
<text top="581" left="506" width="37" height="11" font="2">sapiens </text>
<text top="598" left="108" width="106" height="11" font="2">RepID=6PGD_HUMAN </text>
<text top="598" left="234" width="37" height="11" font="2">P52209 </text>
<text top="615" left="90" width="453" height="11" font="2">10.  cDNA FLJ78120, highly similar to Homo sapiens eukaryotic translation initiation factor 2, subunit </text>
<text top="632" left="108" width="432" height="11" font="2">3  gamma,  52kDa  (EIF2S3),  mRNA  n=1  Tax=Homo  sapiens  RepID=A8K2Y2_HUMAN</text>
<text top="650" left="108" width="3" height="11" font="2"> </text>
<text top="650" left="126" width="60" height="11" font="2">A8K2Y2 (+2) </text>
<text top="667" left="90" width="453" height="11" font="2">11.  cDNA  FLJ75299,  highly  similar  to  Xenopus  laevis  proteasome  (prosome,  macropain)  26S </text>
<text top="684" left="108" width="401" height="11" font="2">subunit, ATPase 3, mRNA n=1 Tax=Homo sapiens RepID=A8K781_HUMAN A8K781 (+1) </text>
</page>
<page number="5" position="absolute" top="0" left="0" height="792" width="612">
<text top="72" left="90" width="450" height="11" font="2">12.  RuvB-like  2  (E.  coli),  isoform  CRA_d  n=1  Tax=Homo  sapiens  RepID=B3KNL2_HUMAN</text>
<text top="90" left="108" width="3" height="11" font="2"> </text>
<text top="90" left="126" width="61" height="11" font="2">B3KNL2 (+2) </text>
<text top="107" left="90" width="338" height="11" font="2">13.  60S ribosomal protein L4 n=1 Tax=Homo sapiens RepID=RL4_HUMAN </text>
<text top="107" left="450" width="58" height="11" font="2">P36578 (+2) </text>
<text top="124" left="90" width="338" height="11" font="2">14.  60S ribosomal protein L3 n=1 Tax=Homo sapiens RepID=RL3_HUMAN </text>
<text top="124" left="450" width="58" height="11" font="2">P39023 (+4) </text>
<text top="141" left="90" width="328" height="11" font="2">15.  Tubulin alpha-1C chain n=2 Tax=Homininae RepID=TBA1C_HUMAN </text>
<text top="141" left="450" width="43" height="11" font="2">Q9BQE3 </text>
<text top="159" left="90" width="453" height="11" font="2">16.  cDNA  FLJ78579,  highly  similar  to  Homo  sapiens  c-src  tyrosine  kinase  (CSK),  mRNA  n=1 </text>
<text top="176" left="108" width="205" height="11" font="2">Tax=Homo sapiens RepID=A8K3B6_HUMAN </text>
<text top="176" left="342" width="60" height="11" font="2">A8K3B6 (+4) </text>
<text top="193" left="90" width="390" height="11" font="2">17.  cDNA FLJ75185 n=1 Tax=Homo sapiens RepID=A8K3D0_HUMAN  A8K3D0 (+10) </text>
<text top="210" left="90" width="453" height="11" font="2">18.  cDNA FLJ16143 fis, clone BRAMY2038516, highly similar to Protein disulfide-isomerase A6 (EC </text>
<text top="228" left="108" width="330" height="11" font="2">5.3.4.1) n=1 Tax=Homo sapiens RepID=B3KY95_HUMAN  B3KY95 (+4) </text>
<text top="245" left="90" width="453" height="11" font="2">19.  cDNA FLJ52929, highly similar to Dolichyl-diphosphooligosaccharide--proteinglycosyltransferase </text>
<text top="262" left="108" width="359" height="11" font="2">48 kDa subunit (EC2.4.1.119) n=1 Tax=Homo sapiens RepID=B4DJE3_HUMAN </text>
<text top="262" left="486" width="39" height="11" font="2">B4DJE3 </text>
<text top="279" left="108" width="21" height="11" font="2">(+3) </text>
<text top="297" left="90" width="453" height="11" font="2">20.  cDNA  FLJ60299,  highly  similar  to  Rab  GDP  dissociation  inhibitor  beta  n=1  Tax=Homo  sapiens </text>
<text top="314" left="108" width="187" height="11" font="2">RepID=B4DLV7_HUMAN  B4DLV7 (+3) </text>
<text top="331" left="90" width="453" height="11" font="2">21.  cDNA  FLJ54023,  highly  similar  to  Heat  shock  protein  HSP  90-beta  n=1  Tax=Homo  sapiens </text>
<text top="348" left="108" width="190" height="11" font="2">RepID=B4DMA2_HUMAN  B4DMA2 (+1) </text>
<text top="366" left="90" width="453" height="11" font="2">22.  cDNA  FLJ56389,  highly  similar  to  Elongation  factor  1-gamma  n=1  Tax=Homo  sapiens </text>
<text top="383" left="108" width="189" height="11" font="2">RepID=B4DTG2_HUMAN  B4DTG2 (+1) </text>
<text top="400" left="90" width="450" height="11" font="2">23.  D-3-phosphoglycerate  dehydrogenase  n=1  Tax=Homo  sapiens  RepID=SERA_HUMAN</text>
<text top="417" left="108" width="3" height="11" font="2"> </text>
<text top="417" left="126" width="38" height="11" font="2">O43175 </text>
<text top="435" left="90" width="294" height="11" font="2">24.  Tubulin beta chain n=12 Tax=Amniota RepID=TBB5_HUMAN </text>
<text top="435" left="414" width="37" height="11" font="2">P07437 </text>
<text top="452" left="90" width="433" height="11" font="2">25.  Elongation factor Tu, mitochondrial n=1 Tax=Homo sapiens RepID=EFTU_HUMAN  P49411 </text>
<text top="469" left="90" width="306" height="11" font="2">26.  Actin-related protein 3 n=4 Tax=Eutheria RepID=ARP3_HUMAN </text>
<text top="469" left="414" width="37" height="11" font="2">P61158 </text>
<text top="486" left="90" width="361" height="11" font="2">27.  Tubulin alpha-4A chain n=8 Tax=Eutheria RepID=TBA4A_HUMAN  P68366 </text>
<text top="504" left="90" width="450" height="11" font="2">28.  Putative  uncharacterized  protein  (Fragment)  n=1  Tax=Homo  sapiens  RepID=Q59G88_HUMAN</text>
<text top="521" left="108" width="3" height="11" font="2"> </text>
<text top="521" left="126" width="61" height="11" font="2">Q59G88 (+1) </text>
<text top="538" left="90" width="450" height="11" font="2">29.  keratin,  type  II  cytoskeletal  7  n=1  Tax=Homo  sapiens  RepID=UPI000013CF9E</text>
<text top="555" left="108" width="3" height="11" font="2"> </text>
<text top="555" left="126" width="99" height="11" font="2">UPI000013CF9E (+1) </text>
<text top="582" left="90" width="3" height="14" font="4">	 Â </text>
</page>
</pdf2xml>
